武汉长联来福制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:14
Drug Approvals
Lyophilizing Thrombin Powder
- Product Name
- 凝血酶散
- Approval Number
- 国药准字H42020983
- Approval Date
- Jun 16, 2023
NMPA
Posterior Pituitary Injection
- Product Name
- 垂体后叶注射液
- Approval Number
- 国药准字H42022292
- Approval Date
- Jun 16, 2023
NMPA
Adenosine Disodium Triphosphate Injection
- Product Name
- 三磷酸腺苷二钠注射液
- Approval Number
- 国药准字H42020985
- Approval Date
- Jun 16, 2023
NMPA
Cytochrome C for Injection
- Product Name
- 注射用细胞色素C
- Approval Number
- 国药准字H42021718
- Approval Date
- Jun 16, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found